How Long After PRP Can I Take NSAIDs?

Most practitioners who perform platelet-rich plasma injections advise avoiding NSAIDs for at least one to two weeks afterward, though published protocols range from less than a week to well over a month. There is no single, universally agreed-upon number because the research community itself is split on how long the restriction should last and whether it matters equally for every type of NSAID. The concern is straightforward: NSAIDs interfere with the very inflammatory cascade that PRP is designed to amplify, so taking them too soon could undermine the treatment. But the details are more nuanced than the blanket “no ibuprofen” instruction you probably got at your appointment.

Why NSAIDs and PRP Work Against Each Other

PRP therapy concentrates your own platelets and injects them into damaged tissue. When those platelets activate, they release growth factors that recruit repair cells to the area and promote healing. A crucial part of this process is inflammation. The swelling, redness, and soreness you feel after a PRP injection are not side effects to suppress; they are the therapeutic mechanism at work. Early-stage inflammation signals your body to start repairing tissue.

NSAIDs do the opposite. They block the production of prostaglandins by inhibiting cyclooxygenase enzymes, and prostaglandins are involved in inflammation, blood clotting, and the kind of tissue-repair signaling that PRP depends on.¹ Beyond dampening inflammation, NSAIDs also directly affect platelet function. Drugs like ibuprofen have well-documented antiplatelet effects, reducing the ability of platelets to aggregate and do their job.² In simple terms, you are paying to have concentrated platelets injected into your joint or tendon, and then taking a pill that tells those platelets to stand down.

What the Published Protocols Actually Recommend

If you search for a definitive post-PRP timeline, you will not find one, because researchers and clinicians have not settled on a standard. A systematic review of PRP injection studies for tendon problems found that while only about a fifth of studies restricted NSAIDs before the injection, more than half restricted them afterward. Among those that did restrict post-injection NSAID use, the most common duration was greater than two weeks.³

For knee osteoarthritis specifically, the picture is similarly inconsistent. A review of 71 PRP studies found that roughly half restricted NSAID use after the injection. Of those that did, about a third had restrictions lasting less than a week, while a larger group restricted use for over a month. Nearly a third of the studies did not mention NSAID restrictions at all.⁴ Another systematic review looking at knee osteoarthritis protocols found postinjection NSAID restriction in about 43% of studies, with the restricted period ranging wildly from one day to nearly five years.⁵

What does all of this actually mean for you? In practice, most sports medicine doctors and orthopedic surgeons land somewhere between one and four weeks of NSAID avoidance after PRP, with two weeks being the most common recommendation. Some are more conservative, extending the window to six weeks. The lack of a hard consensus does not mean the restriction is unimportant; it means the research is still catching up to clinical practice. When your doctor gives you a specific number, they are drawing on their clinical experience and the type of tissue being treated, not a universally validated protocol.

Not All NSAIDs Carry the Same Risk

This is where things get more interesting than the blanket “avoid all NSAIDs” advice suggests. The common over-the-counter painkillers most people reach for, such as ibuprofen and naproxen, are nonselective NSAIDs, meaning they block both COX-1 and COX-2 enzymes. COX-1 is the enzyme most involved in platelet function, which is why these drugs interfere with platelets significantly.

COX-2 selective NSAIDs, such as celecoxib, are a different story. A systematic review found that patients taking nonselective NSAIDs showed significantly decreased platelet aggregation, but those taking COX-2 selective NSAIDs showed no significant difference in platelet aggregation compared to baseline.⁶ This was reinforced by a clinical trial that directly compared celecoxib and ibuprofen, finding that celecoxib did not undermine platelet function the way ibuprofen did.⁷

This distinction matters practically. If your post-PRP pain is severe enough that acetaminophen alone is not cutting it, some physicians will allow a short course of a COX-2 selective NSAID on the rationale that it spares platelet function. This is not a decision to make on your own, but it is worth asking about if you are struggling with pain after your injection. The biology supports the idea that not every NSAID carries the same threat to your PRP results.

Where Aspirin Fits In

Aspirin occupies a unique and confusing space in the PRP conversation. Many patients take low-dose aspirin daily for cardiovascular protection and wonder whether they need to stop before or after a PRP injection. The pharmacology is distinct from other NSAIDs: aspirin irreversibly blocks COX-1, meaning each affected platelet stays impaired for the remainder of its roughly ten-day lifespan. Ibuprofen and naproxen, by contrast, block the enzyme temporarily.

The laboratory evidence on aspirin and PRP is mixed but surprisingly reassuring in some respects. A controlled study in healthy men found that two weeks of daily aspirin use did not change the number of platelets or white blood cells in their PRP. Aspirin did inhibit one pathway of growth factor release from platelets, but it left another major activation pathway largely intact, with the exception of one growth factor (PDGF-AB) that was partially reduced.⁸ In an animal model of rotator cuff tendon disease, PRP combined with aspirin still triggered meaningful changes in gene expression related to collagen production and tissue remodeling compared to saline controls, though the PRP-only group performed better on biomechanical testing.⁹

What this suggests is that aspirin blunts PRP’s effects to some degree rather than completely canceling them. For patients who take daily aspirin for heart protection, the risk of stopping the medication may outweigh the potential reduction in PRP effectiveness. Most physicians who perform PRP will not ask a cardiac patient to stop their aspirin, and the evidence so far supports that approach as reasonable.

Managing Pain Without Undermining the Treatment

The elephant in the room with any post-PRP NSAID restriction is that the injection itself often hurts, and the treated area can ache considerably for several days afterward. Telling someone to avoid their go-to pain reliever right when they need it most is a hard sell, which is why it helps to know the alternatives.

Acetaminophen (Tylenol) is the standard first-line recommendation after PRP. It works through the central nervous system rather than by blocking prostaglandins in the tissue, so it does not interfere with the inflammatory healing response PRP relies on. That said, the systematic review mentioned earlier did note that acetaminophen was associated with decreased platelet aggregation in a small group of patients.⁶ The sample was tiny (13 patients), and clinicians generally still consider acetaminophen safe after PRP, but it is a reminder that even “safe” alternatives are not perfectly neutral.

Ice is commonly recommended in the first 48 to 72 hours, though some practitioners discourage it on the same logic used against NSAIDs: it suppresses inflammation. Others allow icing for short intervals to take the edge off. If you have been told to ice, do so. If you have been told not to, trust your provider’s reasoning for your specific case. Beyond that, elevation, rest, and gentle range-of-motion exercises as tolerated tend to manage the worst of the discomfort until the initial inflammatory phase settles down, usually within a few days to a week.

The PRP Formulation Itself Matters

Not all PRP preparations are the same, and the type you receive may affect how much the NSAID question matters. PRP broadly falls into two categories: leukocyte-rich (LR-PRP), which contains a higher concentration of white blood cells, and leukocyte-poor (LP-PRP), which filters most of them out. Leukocyte-rich preparations tend to trigger a stronger initial inflammatory response.

An animal study tested what happens when you combine a COX-2 selective NSAID (parecoxib) with leukocyte-rich PRP in normal tendons. The NSAID-treated group showed lower inflammation scores at both five and fourteen days compared to the leukocyte-rich PRP group alone.¹⁰ The interpretation is tricky. On one hand, this means the NSAID dampened the response. On the other hand, for leukocyte-rich PRP specifically, some of that intense early inflammation may actually be excessive and counterproductive, especially in tissues like tendons that are not built to handle aggressive inflammatory environments. There is an active debate in the field about whether selectively taming that inflammation with a COX-2 inhibitor could improve outcomes in certain cases rather than harm them.

This nuance rarely makes it into the instruction sheet you get at the clinic. But it does underscore that the “no NSAIDs after PRP” rule is not a one-size-fits-all biological truth. It is a conservative guideline based on the assumption that all post-injection inflammation is beneficial, which may not always be the case depending on the PRP type and the tissue being treated.

How PRP Stacks Up Against Long-Term NSAID Use

An irony of the NSAID restriction is that many patients receiving PRP were taking NSAIDs daily for joint pain before the procedure, and PRP is partly an attempt to break that cycle. A randomized controlled trial comparing a single PRP injection against daily NSAID use for knee osteoarthritis found that the PRP group had significantly better pain and function scores at one year follow-up.¹¹ This does not mean PRP works for everyone or every condition, but it does reframe the short-term NSAID restriction as a temporary trade-off. You are giving up a few weeks of your usual pain reliever for the possibility of reducing or eliminating your need for it over the following months.

For patients who have been on long-term NSAIDs, stopping before the procedure can also be an adjustment. As noted earlier, roughly half of knee osteoarthritis PRP studies excluded patients who had used NSAIDs within five days of the injection.⁵ If you are a chronic NSAID user, your provider may want you off them for several days before the blood draw as well, to give your platelets time to recover their full function before they are concentrated and injected.

When to Talk to Your Doctor Instead of Guessing

A few situations deserve a direct conversation rather than self-managing your post-PRP medication:

• Cardiac aspirin: If you take daily low-dose aspirin prescribed by a cardiologist, do not stop it without clearance from both your cardiologist and the physician performing the PRP. The cardiovascular risk of stopping generally outweighs any marginal benefit to PRP quality.
• Chronic pain conditions: If you rely on NSAIDs to function day to day, your provider needs to plan a bridging strategy before the procedure, not after. Acetaminophen alone may not be enough, and knowing that in advance lets your doctor consider alternatives or adjust the timing.
• Multiple injections: PRP is sometimes given as a series of injections spaced weeks apart. The NSAID restriction window may overlap between sessions, effectively meaning months without your usual pain reliever. This needs to be discussed upfront so you know what you are committing to.
• Prescription NSAIDs: If you are on a prescribed NSAID like meloxicam or diclofenac for a condition like rheumatoid arthritis or ankylosing spondylitis, the decision to stop involves your rheumatologist, not just the PRP provider. These medications may be managing disease activity, not just symptoms.

The variability in published recommendations is not a sign that the science is broken. It reflects the reality that PRP is used across many different tissues and conditions, each with its own healing biology and timeline. A rotator cuff tendon does not heal on the same schedule as knee cartilage, and the ideal NSAID restriction window likely differs between them. Until larger trials standardize these protocols, the safest approach remains the one your specific provider recommends for your specific condition, which for most patients means avoiding ibuprofen, naproxen, and similar nonselective NSAIDs for at least two weeks after the injection, using acetaminophen and ice for pain control in the meantime.